The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.
|Number of pages||6|
|Journal||Journal of Neurosurgical Sciences|
|Publication status||Published - 1985|
ASJC Scopus subject areas
- Clinical Neurology